← back to search

Kimlin Ashing

City Of Hope National Medical Center · US
Area of research
Oncology · Epidemiology
Research interest
Research interests include Global Cancer Incidence and Screening, Cancer survivorship and care, Cervical Cancer and HPV Research, and Cardiovascular Health and Risk Factors.
h-index
22
citations
1,877
works
199
NIH funding
primary concept
Medicine
email

Recent publications

Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update
Journal of Clinical Oncology 2023cited by 235position: middledoi
Abstract A033: The iCCARE Consortium for Prostate Cancer in Black men: Creating a survivorship care plan for Black prostate cancer survivors
Cancer Epidemiology Biomarkers & Prevention 2023cited by 1position: firstdoi
Cancer disparities in the context of rurality: risk factors and screening across various U.S. rural classification codes
Cancer Causes & Control 2022cited by 42position: middledoi
Black Is Diverse: The Untapped Beauty and Benefit of Cancer Genomics and Precision Medicine
JCO Oncology Practice 2021cited by 12position: lastdoi
A pilot randomized trial of an educational intervention to increase genetic counseling and genetic testing among Latina breast cancer survivors
Journal of Genetic Counseling 2020cited by 28position: middledoi
Drivers of cost differences between US breast cancer survivors with or without lymphedema
Journal of Cancer Survivorship 2019cited by 39position: middledoi
A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families
Breast Cancer Research and Treatment 2018cited by 19position: middledoi
A prospective study of changes in anxiety, depression, and problems in living during chemotherapy treatments: effects of age and gender
Supportive Care in Cancer 2017cited by 44position: middledoi
The ConNECT Framework: a model for advancing behavioral medicine science and practice to foster health equity
Journal of Behavioral Medicine 2016cited by 70position: middledoi
Recommendations for Cancer Epidemiologic Research in Understudied Populations and Implications for Future Needs
Cancer Epidemiology Biomarkers & Prevention 2016cited by 39position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Sabrina Ford · Michigan State University2 papers (2016–2022)Jean C. Yi · Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa2 papers (2016–2022)Cathy D. Meade · University of South Carolina2 papers (2016–2022)Usha Menon · Amrita Institute of Medical Sciences and Research Centre2 papers (2016–2022)Sophia George · Sylvester Comprehensive Cancer Center2 papers (2018–2021)Clement K. Gwede · University of South Florida2 papers (2016–2022) · 2 papers (2016–2022) · 1 papers (2019–2019)Kathryn H. Schmitz · UPMC Hillman Cancer Center1 papers (2019–2019) · 1 papers (2020–2020) · 1 papers (2022–2022)Sage Bolte · Inova Health System1 papers (2023–2023)Lorraine T. Dean · Drexel University1 papers (2019–2019)Kristi D. Graves · Georgetown University1 papers (2020–2020)Tram Kim Lam · National Institutes of Health1 papers (2016–2016)Barry S. Berman · Florida Cancer Specialists & Research Institute1 papers (2023–2023)Yusuf Ransome · Yale University1 papers (2019–2019)Kimberly M. Kelly · Roswell Park Comprehensive Cancer Center1 papers (2022–2022) · 1 papers (2016–2016)Getachew Dagne · University of South Florida1 papers (2023–2023)